BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT


Title

Short peptide epitope design from hantaviruses causing HFRS

 

Authors

Sathish Sankar*, Mageshbabu Ramamurthy, Balaji Nandagopal, Gopalan Sridharan

 

Affiliation

Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore 632 055, Tamil Nadu, India.

 

Email

sathish3107@gmail.com;

 

Article Type

Hypothesis

 

Date

Received June 15, 2017; Revised July 3, 2017; Accepted July 5, 2017; Published July 31, 2017

 

Abstract

Several genotypes of the hantavirus cause hemorrhagic fever with renal syndrome (HFRS) and is an important public health problem worldwide. There is now growing interest to develop subunit vaccines especially focused to elicit cytotoxic T lymphocyte responses which are important against viral infection. We identified candidate T-cell epitopes that bind to Class I HLA supertypes towards identifying potential subunit vaccine entity. These epitopes are conserved in all 5 hantavirus genotypes of HFRS (Hantaan, Dobrava-Belgrade, Seoul, Gou virus and Amur). The epitopes identified from S and M segment genomes were analyzed for human proteasome cleavage, transporter associated antigen processing (TAP) efficiency and antigenicity using bioinformatic approaches. The epitope MRNTIMASK which had the two characteristics of high proteasomal cleavage score and TAP score, also had high antigenicity score. Our results indicate that this epitope from the nucleocapsid protein may be considered the most favorable moiety for the development of subunit peptide vaccine.

 

Keywords

Short peptide, epitope design, hantaviruses, HFRS

 

Citation

Sathish Sankar et al. Bioinformation 13(7): 231-236 (2017)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.